💸 A Series A extension: US-China biotech Degron Therapeutics has collected an additional $40 million for its molecular glue degrader platform. The San Diego and Shanghai biotech has raised $95 million …
Andrea Pfeifer ends 23-year reign at AC Immune; Acadia’s top R&D exec announces retirement
AC Immune will be searching for a new CEO for the first time, as the company announced this week that Andrea Pfeifer plans to retire

